Finally, J. Craig Venter is taking the next big step. The scientist who, as president of Celera Genomics, throttled up the historic push to decode the human genome, is stepping into the realm of prevention and precision medicine. Venter's ambitions go beyond using genetic information for patient care. Through his firm Human Longevity, Inc., Venter aims to build a million-person database by 2020 as a resource to understand the complex relationship between genes and biology, including human disease. "We're rewriting the definition of health," Venter says. Read More...